logo
logo
Sign in

Neurodiagnostics Market Current and Future Trends, Leading Players, Segments and Regional Forecast 2027

avatar
Market Media Hub
Neurodiagnostics Market Current and Future Trends, Leading Players, Segments and Regional Forecast 2027

Market Research Future (MRFR) confirms that the Neurodiagnostics market 2020 can procure a growth rate of 6.88% over the appraisal period (between 2019 and 2025). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.


Although SARS-CoV-2 does not cause any neurological disease, it can still lead to CNS/central nervous system infection, along with para-infectious issues. More than a million novel coronavirus cases have been reported across the world, despite the lockdown imposed. However, definitive proof is insufficient to say that neurological disorders are associated with the pandemic. Currently, the healthcare is primarily focused on dealing with the COVID-19 outbreak, and the focus on Neurodiagnostics has gone down to some extent.


With that said, the surging life expectancy and the consequent expansion of the elderly population can be favorable for the Neurodiagnostics market. Since the geriatric populace has increased, age-associated neurological diseases like Alzheimer’s disease, stroke, dementia and Parkinson’s disease have also gathered prevalence at the same time. The biomarker trend is also gaining momentum worldwide, as it is an efficient approach to understand how neurological diseases develop. Biomarkers are increasingly being used to evaluate and measure the therapeutic status. Considering biomarkers’ growth potential, firms are progressively spending on research and development in this regard, which could benefit the global market in the next few years.


Accelerated knowledge among people due to efforts being given by government organizations with regard to neurological diseases has positively shaped the market. A robust research base has created a number of lucrative opportunities for the renowned firms in the global market. For instance, in July 2020, a team of researchers developed an in-vitro biological neuronal network over a multi-electrode array, while running an artificial spiking neural network over a Field Programmable Gate Array board. The research helped understand the application scope of SNN in neuro-prosthetic tools and devices used for replacing wounded micro-circuitries that are able to communicate inside big brain networks.


Key Players 

Some of the most renowned players in the global market are Lifelines Neuro Company, LLC (US), QIAGEN N.V. (Netherlands), Hitachi, Ltd. (Japan), GE Healthcare (US), Thermo Fisher Scientific, Inc. (US), Philips Healthcare (Netherlands), Hoffman-La Roche AG (Switzerland), Natus Medical Incorporated (US), FUJIFILM Holdings Corporation (Japan), Siemens Healthineers (Germany), Canon, Inc. (Japan), Mitsar Co., Ltd. (Russia), to name a few.


Segmental Review 

The Neurodiagnostics industry has been considered for product, condition, and end user.


  • The market, with respect to the product type, caters to clinical diagnostic instruments, reagents & consumables, and diagnostic imaging systems.
  • Neurodiagnostic market, depending on the condition, covers stroke, sleep disorders, neurodegenerative diseases, headache disorders, epilepsy, and more.
  • The significant market end-users identified in the report are diagnostic laboratories & imaging centers, hospitals & surgical centers, ambulatory care centers, research laboratories & academic institutes and neurology centers.


Regional Insight 

The worldwide market can be regionally considered for Europe/EU, the Middle East & Africa/MEA, Asia Pacific/APAC, and the Americas.


As of 2018, the Americas has been the highest gainer in the global market, thanks to the escalating cases of neurological disorders across the US and Canada. The surge in cases of ischemic stroke, stroke, migraine, epilepsy and Parkinson’s disease coupled with the high frequency of technological innovations in this field benefits the market here. In recent years, a rise in studies with regard to biomarkers has been observed in the region, which can be a significant market trend in the coming years. Also, most of the firms in the region are focused on developing ELISA kits and protein assays that help diagnose Alzheimer’s disease.


The APAC market for neurodiagnostics is split into emerging countries of Japan, Australia, India, China and South Korea. The APAC market has been performing well, due to the expanding patient pool, mounting awareness level of patients, and the increasing spending on the healthcare sector. The increasing deployment of new and modern diagnostic technologies along with the growing geriatric populace suffering from epilepsy, Parkinson disease, stroke and migraine can also enhance the market size in the ensuing period.


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. 


Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited), 

99 Hudson Street,5Th Floor, New York, New York 10013, 

United States of America

+1 646 845 9312

Email: [email protected]

collect
0
avatar
Market Media Hub
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more